Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps
Primary Objective:
To evaluate the efficacy of dupilumab compared to placebo on a background of mometasone furoate nasal spray (MFNS) in reducing nasal congestion/obstruction (NC) severity and endoscopic nasal polyposis score (NPS) in patients with bilateral nasal polyposis (NP). In addition for Japan, reduction in computed tomography (CT) scan opacification of the sinuses will be also a co-primary objective.
Secondary Objectives:
To evaluate the efficacy of dupilumab in improving total symptoms score (TSS).
Status
Closed for Recruitment